NOVAVAX INC Collaboration Agreements
5 Contracts & Agreements
- Change Order No. 1 to the Collaboration and Exclusive License Agreement between Novavax, Inc. and SK Bioscience Company Limited, dated as of March 31, 2022 (Filed With SEC on May 10, 2022)
- Statement of Work No. 1 to Collaboration and Exclusive License Agreement between the Company and SK bioscience Company Limited, dated as of December 23, 2021 (Filed With SEC on March 1, 2022)
- Amendment to Collaboration and Exclusive License Agreement between the Company and SK bioscience Company Limited, dated as of December 23, 2021 (Filed With SEC on March 1, 2022)
- Collaboration and Exclusive License Agreement between Novavax, Inc. and Takeda Pharmaceutical Company Limited, dated as of February 24, 2021 (Filed With SEC on May 10, 2021)
- Collaboration and Exclusive License Agreement between Novavax, Inc. and SK Bioscience Company Limited, dated as of February 12, 2021 (Filed With SEC on May 10, 2021)
